Phase I study of dalteparin in combination with sunitinib as first-line treatment in patients with metastatic renal cell carcinoma

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Journal	Journal of clinical oncology
Volume	32
Issue number	suppl abstr e15607
Publication status	Published - 2014

Cite this

@article{b79faafd880142ce9cddf92b498efae4,

title = "Phase I study of dalteparin in combination with sunitinib as first-line treatment in patients with metastatic renal cell carcinoma",

author = "J Voortman",

year = "2014",

language = "English",

volume = "32",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "suppl abstr e15607",

}